EHA.
- Published in:
- Oncology (08909091), 2025, v. 39, n. 7, p. 310
- Publication type:
- Article
Works matching IS 08909091 AND DT 2025 AND VI 39 AND IP 7
Results: 8
1
2
ASCO.
- Published in:
- Oncology (08909091), 2025, v. 39, n. 7, p. 302
- Publication type:
- Article
3
Unveiling the Potential of Zenocutuzumab: A Breakthrough in NSCLC and Pancreatic Adenocarcinoma Treatment.
- Published in:
- Oncology (08909091), 2025, v. 39, n. 7, p. 298
- By:
- Publication type:
- Article
4
GLP-1 Receptor Agonist Use and Weight Change in Patients With Breast Cancer.
- Published in:
- Oncology (08909091), 2025, v. 39, n. 7, p. 294
- By:
- Publication type:
- Article
5
Male Cancer Survivors in Physically Demanding Jobs Need More Support.
- Published in:
- Oncology (08909091), 2025, v. 39, n. 7, p. 292
- Publication type:
- Article
6
A Phase 2 Study of Docetaxel and Capecitabine in Advanced Squamous Cell Carcinoma of the Head and Neck.
- Published in:
- Oncology (08909091), 2025, v. 39, n. 7, p. 284
- By:
- Publication type:
- Article
7
Safeguarding Vulnerability: COVID-19's Impact on Immunocompromised Patients With Cancer.
- Published in:
- Oncology (08909091), 2025, v. 39, n. 7, p. 280
- By:
- Publication type:
- Article
8
New Colon Cancer Data Shows Importance of Exercise Therapy for Survival.
- Published in:
- Oncology (08909091), 2025, v. 39, n. 7, p. 279
- By:
- Publication type:
- Article